7096 StemCell Instituteステムセル研究所TSE Growth / Services
0 posts
StemCell Institute (7096) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
StemCell Institute (7096) Stock Price HistoryNear an all-time low
StemCell Institute closed at ¥620 on Nov 20, 2026, −13.5% over 1 month, −18.0% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥86,471 today (−13.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −13.5%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥620 | −20 | −3.13% |
| Nov 19 (Thu) | ¥640 | −3 | −0.47% |
| Nov 18 (Wed) | ¥643 | +3 | +0.47% |
| Nov 17 (Tue) | ¥640 | +0 | +0.00% |
| Nov 16 (Mon) | ¥640 | −11 | −1.69% |
| Nov 13 (Fri) | ¥651 | −27 | −3.98% |
| Nov 12 (Thu) | ¥678 | +10 | +1.50% |
| Nov 11 (Wed) | ¥668 | +25 | +3.89% |
| Nov 10 (Tue) | ¥643 | +8 | +1.26% |
| Nov 9 (Mon) | ¥635 | −4 | −0.63% |
If you had invested ¥100,000 3 months ago, it would be worth ¥80,000 today (−20.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −20.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥620 | −20 | −3.13% |
| Nov 19 (Thu) | ¥640 | −3 | −0.47% |
| Nov 18 (Wed) | ¥643 | +3 | +0.47% |
| Nov 17 (Tue) | ¥640 | +0 | +0.00% |
| Nov 16 (Mon) | ¥640 | −11 | −1.69% |
| Nov 13 (Fri) | ¥651 | −27 | −3.98% |
| Nov 12 (Thu) | ¥678 | +10 | +1.50% |
| Nov 11 (Wed) | ¥668 | +25 | +3.89% |
| Nov 10 (Tue) | ¥643 | +8 | +1.26% |
| Nov 9 (Mon) | ¥635 | −4 | −0.63% |
If you had invested ¥100,000 6 months ago, it would be worth ¥97,331 today (−2.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −2.7%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥620 | −11.6% |
| Oct 2026 | ¥701 | −2.8% |
| Sep 2026 | ¥721 | −5.8% |
| Aug 2026 | ¥765 | +7.7% |
| Jul 2026 | ¥710 | −1.9% |
| Jun 2026 | ¥724 | +10.9% |
| May 2026 | ¥653 | −12.5% |
If you had invested ¥100,000 1 year ago, it would be worth ¥82,011 today (−18.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −18.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥620 | −11.6% |
| Oct 2026 | ¥701 | −2.8% |
| Sep 2026 | ¥721 | −5.8% |
| Aug 2026 | ¥765 | +7.7% |
| Jul 2026 | ¥710 | −1.9% |
| Jun 2026 | ¥724 | +10.9% |
| May 2026 | ¥653 | −12.5% |
| Apr 2026 | ¥746 | −2.6% |
| Mar 2026 | ¥766 | −15.7% |
| Feb 2026 | ¥909 | +10.6% |
| Jan 2026 | ¥822 | +3.7% |
| Dec 2025 | ¥793 | +2.5% |
| Nov 2025 | ¥774 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥26,678 today (−73.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −73.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥620 | −21.8% |
| 2025 | ¥793 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥23,006 today (−77.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −77.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥620 | −21.8% |
| 2025 | ¥793 | ― |
If you had invested ¥100,000 in Jun 2021, it would be worth ¥30,024 today (−70.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.0%, while this stock moved −70.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥620 | −21.8% |
| 2025 | ¥793 | −38.5% |
| 2024 | ¥1,289 | −39.9% |
| 2023 | ¥2,144 | −17.5% |
| 2022 | ¥2,598 | +9.2% |
| 2021 | ¥2,380 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jun 2021). Please check the latest prices before trading.
StemCell Institute (7096) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of StemCell Institute (7096)
Business overview
The company runs a bank for cells derived from perinatal tissue, such as cord blood and umbilical cord, for use in regenerative medicine and cell therapy. The umbilical cord and cord blood, the blood in the cord and placenta, contain cells being studied for their role in suppressing inflammation and repairing tissue, and since they can be stored long-term, there is demand to keep them for future medical use. The company runs these cell banks and develops new treatments using the cells, and through STEMCELL INNOVATIONS PTE. LTD. in Singapore and Milcare it is also pursuing overseas storage and related new businesses. It operates a single cell bank segment.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Services (532 companies)
| PER | 60.1x | Above the sector median of 12.9x (No. 425 from the lowest) |
|---|---|---|
| PBR | 2.29x | Above the sector median of 1.49x (No. 381 from the lowest) |
| ROE | 3.81% | No. 401 in the sector (highest first); median 12.16% |
| Market cap | ¥6.2 bn | No. 306 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥909 | 2/27 |
|---|---|---|
| 52-week low | ¥620 | 11/20 |
| Current position | 0.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥620) |
| Year to date | -21.8% | No. 370 of 524 in the sector (best first) |
| 1 year | -18.0% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/12 15:302027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)
- 11/12 15:302027年3月期 第2四半期 決算説明資料
Filings from the past 12 months (2).
Shareholder benefits of StemCell Institute
Details and disclosure history of StemCell Institute's shareholder benefits
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.